Abbott Laboratories Share Price Deutsche Boerse AG
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Tradegate
12:19:39 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 89.32 EUR | +1.11% |
|
-0.45% | -16.25% |
| 10:50pm | Trinity Heart Experts First in the Quad Cities to Use New Afib Technology | CI |
| 17/09 | Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026 | CI |
| Market Cap | 18TCr 15TCr 15TCr 13TCr 25TCr 16,97400Cr 25TCr 1,74500Cr 67TCr 8,63000Cr 66TCr 65TCr 27,76800Cr | P/E 2026 * |
29x | P/E 2027 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 20TCr 18TCr 17TCr 15TCr 28TCr 19,27100Cr 28TCr 1,98100Cr 76TCr 9,79800Cr 75TCr 74TCr 31,52500Cr | EV / Sales 2026 * |
4x | EV / Sales 2027 * | 3.63x |
| Free-Float |
86.16% | Yield 2026 * |
2.51% | Yield 2027 * | 2.68% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
Xetra
| ABL | Delayed | |
|
CBOE
| Real-time | ||
|
London S.E.
| ABT | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABT | End-of-day quote | |
|
CBOE
| ABT | Real-time | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +1.09% | ||
| 1 week | -0.45% | ||
| Current month | -8.61% | ||
| 1 month | -9.00% | ||
| 3 months | +14.46% | ||
| 6 months | -7.13% | ||
| Current year | -16.25% |
| 1 week | 88.02 |  | 89.84 |
| 1 month | 88.02 | | 100.5 |
| Current year | 69.76 | | 109.34 |
| 1 year | 69.76 | | 116.8 |
| 3 years | 69.76 | | 133.78 |
| 5 years | 69.76 | | 133.78 |
| 10 years | 34.46 | | 133.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.11% | -0.45% | - | - | 18TCr | |
| +0.33% | +0.51% | -23.85% | +1.46% | 18TCr | |
| -0.13% | +1.76% | -3.17% | +11.79% | 12TCr | |
| +0.64% | -3.44% | +6.76% | +73.43% | 5.9TCr | |
| -0.50% | +1.43% | -4.23% | -31.81% | 4.94TCr | |
| -0.22% | -2.29% | +5.98% | +35.20% | 4.86TCr | |
| +1.72% | +7.48% | +17.76% | -6.35% | 3.32TCr | |
| -0.64% | -1.77% | - | - | 2.82TCr | |
| -1.12% | +4.91% | +42.45% | -7.95% | 2.58TCr | |
| +1.02% | +5.99% | +7.20% | -19.54% | 2.19TCr | |
| Average | +0.23% | +1.47% | +6.11% | +7.03% | 6.24TCr | |
| Weighted average by Cap. | +0.37% | +0.36% | -4.26% | +9.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.02TCr 4.38TCr 4.13TCr 3.75TCr 7.03TCr 4,81700Cr 7.06TCr 50TCr 19TCr 2,44900Cr 19TCr 18TCr 7,88100Cr | 5.45TCr 4.75TCr 4.49TCr 4.08TCr 7.64TCr 5,23200Cr 7.67TCr 54TCr 21TCr 2,66000Cr 20TCr 20TCr 8,55900Cr |
| Net income | 630.32Cr 549.64Cr 518.98Cr 471.27Cr 882.98Cr 60TCr 886.66Cr 6.22TCr 2.4TCr 31TCr 2.37TCr 2.32TCr 99TCr | 797.76Cr 695.65Cr 656.85Cr 596.47Cr 1.12TCr 77TCr 1.12TCr 7.87TCr 3.04TCr 39TCr 3TCr 2.93TCr 1,25200Cr |
| Net Debt | 2.39TCr 2.09TCr 1.97TCr 1.79TCr 3.35TCr 2,29700Cr 3.37TCr 24TCr 9.11TCr 1,16800Cr 8.99TCr 8.79TCr 3,75800Cr | 2.1TCr 1.83TCr 1.73TCr 1.57TCr 2.94TCr 2,01100Cr 2.95TCr 21TCr 7.98TCr 1,02200Cr 7.87TCr 7.7TCr 3,29000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | €88.36 | +0.02% | 75 |
| 17/26/17 | €88.34 | -1.67% | 250 |
| 16/26/16 | €89.84 | +0.92% | 536 |
| 15/26/15 | €89.02 | -0.51% | 0 |
| 14/26/14 | €89.48 | +0.81% | 27 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
Select your edition
All financial news and data tailored to specific country editions
